Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Intercept Pharmaceuticals
(NQ:
ICPT
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Nov 7, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Intercept Pharmaceuticals
< Previous
1
2
3
4
5
6
7
Next >
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
September 30, 2022
This has been a "historically challenging" population to treat.
Via
Investor's Business Daily
Why Carnival Shares Are Trading Lower By 19%, Here Are 49 Stocks Moving In Friday's Mid-Day Session
September 30, 2022
Gainers
Via
Benzinga
Why Is Intercept Pharmaceuticals (ICPT) Stock Down 20% Today?
September 30, 2022
Market traders watched Intercept's recent clinical trial with anticipation. Unfortunately, the results fell short and ICPT stock is tanking.
Via
InvestorPlace
Wall Street Mixed; Dow Drops Over 50 Points
September 30, 2022
U.S. stocks traded mixed this morning, with the Dow Jones dropping more than 50 points on Friday.
Via
Benzinga
Intercept Pharma Summarizes Key Actions in Strategic Financial Repositioning
September 21, 2022
Via
Benzinga
Intercept Settles Ocaliva Litigation With Reddy's Lab
August 17, 2022
Via
Benzinga
Intercept Pharmaceutical Stock Sees RS Rating Rise To 91
September 27, 2022
Intercept Pharmaceutical shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Via
Investor's Business Daily
Why Stabilis Solutions Shares Jumped Over 71%; Here Are 70 Biggest Movers From Yesterday
September 22, 2022
Gainers
Via
Benzinga
Where Intercept Pharmaceuticals Stands With Analysts
August 04, 2022
Within the last quarter, Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings:
Via
Benzinga
Intercept Shares Jump After Reissuing Annual Guidance
August 03, 2022
Intercept Pharmaceuticals Inc (NASDAQ: ICPT) completed the sale of its international business for $405 million in upfront consideration.
Via
Benzinga
Needham Cuts Price Target On This NASH-Focused Stock As Its Awaits Visibility On Regulatory Path
July 08, 2022
Via
Benzinga
Why Adamis Pharmaceuticals Is Trading Lower By Around 44%, Here Are 46 Stocks Moving In Wednesday's Mid-Day Session
September 21, 2022
Gainers
Via
Benzinga
What Is Going on With Clovis Oncology (CLVS) Stock Today?
September 21, 2022
Clovis Oncology (CLVS) stock is getting a boost on Wednesday as investors react to news of it reaching a two-year clinical supply agreement.
Via
InvestorPlace
Why Freyr Battery (FREY) Stock Could Be the Best EV Bet
September 21, 2022
Freyr Battery (FREY) stock is a hot topic among traders on Wednesday after Morgan Stanley weighed in on the electric vehicle (EV) company.
Via
InvestorPlace
Why Is Intercept Pharmaceuticals (ICPT) Stock Up Today?
September 21, 2022
Intercept Pharmaceuticals (ICPT) stock is on the move Wednesday after giving investors an update on how it improved its financials.
Via
InvestorPlace
Intercept Pharmaceutical Stock Shows Market Leadership; Earns 92 RS Rating
August 30, 2022
On Tuesday, Intercept Pharmaceutical stock had its Relative Strength Rating upgraded to 92, up from 89 a day earlier.
Via
Investor's Business Daily
Short Interest Sector Focus: Healthcare Sector
August 30, 2022
As of the close of business on Monday, 8/29, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Intercept Pharmaceuticals
August 22, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Raymond James Maintains Outperform Rating for Intercept Pharmaceuticals: Here's What You Need To Know
August 22, 2022
Raymond James has decided to maintain its Outperform rating of Intercept Pharmaceuticals (NASDAQ:ICPT) and raise its price target from $26.00 to $28.00. Shares of Intercept Pharmaceuticals are trading...
Via
Benzinga
Stocks That Made New Highs On Friday, Aug. 19
August 21, 2022
On Friday, in spite of the stock market being down, there were several stocks that actually made new highs.
Via
Talk Markets
General Motors, Foot Locker And Some Other Big Stocks Recording Gains On Friday
August 19, 2022
GigaCloud Technology Inc (NASDAQ: GCT) shares jumped 145% to $38.45 on continued volatility following the company's IPO on Thursday.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
August 17, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 12, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Intercept Pharmaceuticals: Q2 Earnings Insights
August 03, 2022
Intercept Pharmaceuticals (NASDAQ:ICPT) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Short Interest Sector Focus: Healthcare Sector
July 29, 2022
As of the close of business on Thursday, 7/28, we captured the Top 10 Highest Short Interest % stocks within the Healthcare Sector. The average short interest for stocks within the Healthcare sector...
Via
Benzinga
7 Biotech Stocks to Buy for Q3
July 18, 2022
These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.
Via
InvestorPlace
Analyst Ratings for Intercept Pharmaceuticals
July 08, 2022
Over the past 3 months, 4 analysts have published their opinion on Intercept Pharmaceuticals (NASDAQ:ICPT) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Why Did Intercept Pharmaceuticals (ICPT) Stock Fall 10% Today?
July 07, 2022
A fresh press release from Intercept Pharmaceuticals reveals positive data from an important clinical trial. Yet, ICPT stock is dropping.
Via
InvestorPlace
This EV Maker Stock Jumps More Than 9%, Here's 46 Stocks Moving In Thursday's Mid-Day Session
July 07, 2022
Gainers United Maritime Corporation (NASDAQ: USEA) jumped 180.4% to $8.02. The company’s stock jumped 190% on Wednesday after completing its spin-off from Seanergy Maritime Holdings Corp.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.